In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Mupirocin, Lithium Salt Drug Master File in Korea (Mupirocin, Lithium Salt KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Mupirocin, Lithium Salt. The MFDS reviews the Mupirocin, Lithium Salt KDMF as part of the drug registration process and uses the information provided in the Mupirocin, Lithium Salt KDMF to evaluate the safety and efficacy of the drug.
After submitting a Mupirocin, Lithium Salt KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Mupirocin, Lithium Salt API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Mupirocin, Lithium Salt suppliers with KDMF on PharmaCompass.